Landscape Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,628
| Closed | -$1.03M | – | 801 |
|
|
2025
Q1 | $1.03M | Buy |
+1,628
| New | +$1.03M | 0.09% | 290 |
|
|
2019
Q4 | – | Sell |
-1,259
| Closed | -$349K | – | 798 |
|
|
2019
Q3 | $349K | Sell |
1,259
-699
| -36% | -$194K | 0.03% | 494 |
|
|
2019
Q2 | $613K | Hold |
1,958
| – | – | 0.05% | 370 |
|
|
2019
Q1 | $804K | Sell |
1,958
-103
| -5% | -$42.3K | 0.08% | 307 |
|
|
2018
Q4 | $770K | Buy |
2,061
+138
| +7% | +$51.6K | 0.06% | 330 |
|
|
2018
Q3 | $777K | Buy |
+1,923
| New | +$777K | 0.06% | 318 |
|
|
2018
Q1 | – | Sell |
-2,143
| Closed | -$806K | – | 634 |
|
|
2017
Q4 | $806K | Buy |
+2,143
| New | +$806K | 0.07% | 286 |
|
|
2014
Q2 | – | Sell |
-800
| Closed | -$240K | – | 350 |
|
|
2014
Q1 | $240K | Buy |
+800
| New | +$240K | 0.32% | 79 |
|